COMP <GO>
RVP vs UNH // PIOTROSKI F-SCORE QUALITY
Retractable Technologies Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: RVP 1
— UNH 9
▲ PIOTROSKI F-SCORE QUALITY LEADER: UNH
LAST: $0.57 (+0.18%) • MKT CAP: $16.9M
piotroski-score
3/9
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RVP VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RVP | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 0.10% | 88.31% | -88.21 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -23.30% | 12.38% | -35.68 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 6.25% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -55.30% | 5.32% | -60.62 | UNH | /operating-margins <GO> |
| Net Profit Margin | -32.80% | 3.53% | -36.33 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 15.80% | 3.33% | +12.47 | RVP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.52 | 3.09 | -2.57 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 7/9 | -4.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.5 | 55.1 | -23.60 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.9M | $359.43B | -$359.42B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RVP REV | UNH REV | RVP GROSS % | UNH GROSS % | RVP FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $38.3M | $447.57B | 0.1% | 88.7% | -$7.1M | $16.07B |
| FY 2024 | $33.0M | $400.28B | -3.1% | 88.3% | -$13.0M | $20.70B |
| FY 2023 | $43.6M | $371.62B | — | 89.6% | $2.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RVP // BETA —
UNH // BETA 0.33